Genetic Testing and IVF: What It Checks and Who Needs It
By day five or six, an IVF embryo has sorted itself into two groups of cells, one that forms the placenta and one that forms the baby. Genetic testing takes its sample from the outer, placenta-forming group, so the inner group stays untouched.
That small biopsy sits behind every embryo test discussed here. This guide covers what the tests look for, who is commonly offered them, where their limits lie, and which questions are worth taking to a fertility specialist.
How Does Genetic Testing for IVF Actually Work?
Genetic testing for IVF comes in two forms, and people often mix them up. One tests the embryo. The other tests the parents beforehand, usually with a blood sample.
Embryo testing starts after fertilization. Once the embryo reaches the blastocyst stage, an embryologist removes a few cells and sends them to a genetics lab. Results can take days, so embryos are often frozen while the lab works and transferred in a later cycle.
Parental testing happens earlier. A karyotype looks at the number and structure of a person’s chromosomes, and carrier screening checks whether someone silently carries a gene for a recessive condition. Neither involves an embryo at all.
What IVF Genetic Screening Looks For
Three tests sit behind the acronyms, and clinics still use older names for two of them.
PGT-A, formerly called PGS, counts chromosomes. An embryo with an extra or missing chromosome often fails to implant or ends in early miscarriage, so this test aims to flag those embryos before transfer.
PGT-M, formerly PGD, looks for one specific single-gene condition that a family already knows about. Thalassemia and sickle cell disease are typical examples, and both are well documented in Oman.
PGT-SR deals with structural rearrangements. If a parent carries a balanced translocation, meaning chromosome pieces have swapped places without any loss, their embryos can inherit an unbalanced version. This test checks for exactly that.
Who May Need Genetic Testing Before or During IVF
Nobody needs it by default. A specialist usually raises it when the history points to a reason.
A known inherited condition is the clearest one, especially when both partners carry the same recessive gene. A parent with a chromosomal rearrangement is another. Repeated miscarriage comes up often, as do several failed transfers with embryos that looked healthy under the microscope.
Age plays a part too. Chromosome errors in eggs become more common as a woman gets older, which is why PGT-A is discussed more often in that group.
For men, severe male-factor infertility can prompt a karyotype or a Y-chromosome microdeletion test, since some cases of very low or absent sperm count have a genetic cause. Both partners are assessed before any of this is decided, which keeps the plan grounded in facts rather than assumptions.
What Genetic Testing for Fertility Can and Cannot Tell You
Results feel definitive. They are not, quite.
Researchers still debate whether PGT-A improves live birth rates, particularly for younger patients, and professional societies have been cautious about recommending it for everyone. Some embryos also come back mosaic, a mix of normal and abnormal cells, and how to handle those is a judgment call between patient and doctor.
Testing covers only what it was designed to find. A PGT-A result says nothing about a single-gene condition, and no embryo test replaces diagnostic testing during pregnancy. It also adds cost and time to a cycle, and no result can promise a pregnancy.
Finding IVF Genetic Testing in Oman: Questions to Bring
- Which test is being suggested, and what in your history points to it?
- How mosaic or unclear results are handled?
- Where samples are analyzed and how long results take?
- What will happen to embryos that are not transferred?
- The extra cost, written down?
Final Thoughts
Genetic testing gathers information. It helps most when there is a clear medical reason and both partners have been evaluated first. Before your consultation, write down your family history and the details of any past cycles. Which of those details do you think your doctor most needs to hear?
FAQ
No. Doctors usually suggest it when there is a reason, like a known inherited condition, repeated miscarriage, several failed transfers, or a chromosome rearrangement in a parent. For many couples the workup shows no need for it.
PGT-A counts chromosomes in an embryo. PGT-M looks for one specific inherited gene condition your family already knows about. Different questions, different tests, and your doctor picks based on your history.
Never. It screens for what it was built to find and nothing else. Results can be unclear, like mosaic embryos, and prenatal checks still matter later. Think of it as extra information, not a promise.
Testing removes a few cells from the outer layer that forms the placenta, not the part that becomes the baby. No procedure is risk-free, so ask your clinic about its own experience with embryo biopsy.
Often, yes. Both partners are usually evaluated before a plan is set, and that can include a karyotype or carrier screening. Those results tell the specialist whether embryo testing makes sense at all.
Related Post
